Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Study on Type 2 Diabetes Mellitus Patient's Characteristics and Management by General Practitioners and Endocrinologists in the Russian Population (THESEUS)

NCT03209089 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03209089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Study on Type 2 Diabetes Mellitus Patient's Characteristics and Management by General Practitioners and Endocrinologists in the Russian Population (THESEUS)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 7, 2017
Completion date
April 15, 2019
Enrollment
907 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus